XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Jun. 29, 2024
Sep. 30, 2023
Current assets:    
Cash and cash equivalents $ 25,565 $ 29,965
Marketable securities 36,236 31,590
Accounts receivable, net 22,795 29,508
Vendor non-trade receivables 20,377 31,477
Inventories 6,165 6,331
Other current assets 14,297 14,695
Total current assets 125,435 143,566
Non-current assets:    
Marketable securities 91,240 100,544
Property, plant and equipment, net 44,502 43,715
Other non-current assets 70,435 64,758
Total non-current assets 206,177 209,017
Total assets 331,612 352,583 Close
Current liabilities:    
Accounts payable 47,574 62,611
Other current liabilities 60,889 58,829
Deferred revenue 8,053 8,061
Commercial paper 2,994 5,985
Term debt 12,114 9,822
Total current liabilities 131,624 145,308
Non-current liabilities:    
Term debt 86,196 95,281
Other non-current liabilities 47,084 49,848
Total non-current liabilities 133,280 145,129
Total liabilities 264,904 290,437 Close
Commitments and contingencies
Common stock, shares outstanding (in shares) 15,222,259 15,550,061
Common stock, shares issued (in shares) 15,222,259 15,550,061
Shareholders’ equity:    
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 15,222,259 and 15,550,061 shares issued and outstanding, respectively $ 79,850 $ 73,812
Accumulated deficit (4,726) (214)
Accumulated other comprehensive loss (8,416) (11,452)
Total shareholders’ equity 66,708 62,146 Close
Total liabilities and shareholders’ equity $ 331,612 $ 352,583